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Introduction
The sequential differentiation of keratinocytes in
the epidermis is a complex, highly regulated series
of events that results in the formation of the anu-
cleate cornified cells of the stratum corneum from
the relatively undifferentiated cells of the basal
layer. This differentiation process is calcium de-
pendent and requires extensive and tightly con-
trolled changes in both protein expression and en-
zymatic activities resulting in characteristic
morphological changes of the cells. Proteolytic
processing is an important mechanism for many of
these events, including signaling, proprotein acti-
vation, structural remodeling and desquamation.
A number of different proteases have been iden-
193
tified that play a role in epidermal differentiation.
These include calpain I (1), cathepsins C (2, 3), B,
H and L (4), profilaggrin endopeptidase (PEP1)
(5), the stratum corneum chymotryptic-like pro-
tease (SCCP) and the stratum corneum thiol pro-
tease (SCTP) (6). The importance of proteases in
the epidermis is highlighted by the finding that null
mutations of cathepsin C result in palmoplantar
keratoderma disorders, specifically Haim–Munk
and Papillon–Lefevre syndromes (2, 7, 8).
A protease family that has been implicated in
processing and differentiation in a number of
tissues is the Proprotein Convertase (PC) family.
This is a family of Ca2π-dependent serine pro-
teases related to bacterial subtilisin (for reviews see
9–12). To date 7 family members have been iden-
Pearton et al.
tified; furin (also known as PACE), PC2, PC1/3,
PACE4, PC4, PC5/6 and PC7/8/LPC. Of these fur-
in, PACE4, PC5/6 and PC7/8 are widely expressed
whereas PC2 and PC1/3 are limited to neuro-endo-
crine tissues and PC4 is restricted to the testis, sug-
gesting both generalized and tissue-specific pat-
terns of expression and function. The PC enzymes
recognize basic motifs, cleaving after paired basic
residues (PC2 and PC1/3) or after a canonical
RX(R/K)R motif (furin and PACE4); in some sub-
strates a P6 Arg can substitute for the Arg at the
P4 position (13). Furin has been shown to process
a wide variety of substrates including receptors,
growth factors, hormones, plasma proteins, matrix
metalloproteinases and extracellular matrix com-
ponents. In addition PC family members are also
involved in the processing of exogenous proteins
such as some viral envelope glycoproteins and bac-
terial endotoxins (12).
Several proteins relevant to keratinocyte devel-
opment have been shown to be substrates for PC
processing or contain potential PC cleavage sites.
These include receptors such as Notch-1 (14, 15),
matrix components such as collagen XVII (BP180)
(16), matrix metalloproteinases, desmosomal com-
ponents such as desmoplakin-1 and desmoglein,
integrins including integrins a3 and a6 (17) and
structural proteins such as profilaggrin.
Although PCs have diverse substrates and play
a role in differentiation in some systems there has
been no systematic study of PC expression in epi-
dermis (2). We therefore investigated the express-
ion and distribution of the members of the PC
family in epidermis and examined the processing
of several potential substrates.
In this study, 4 members of the PC family (furin,
PACE4, PC5/6 and PC7/8) were detected in epider-
mis. Furin and PC7/8 were detected in distinct, al-
though overlapping, patterns within the epidermis.
In addition the active site of furin showed differen-
tial accessibility during differentiation. Inhibition
of the PC family in culture inhibited the processing
of Notch-1 and in vitro results characterized a fur-
in/PACE4 processing site in the amino terminus of
profilaggrin. The specific localization pattern, cal-
cium dependence, and identification of possible
substrates are consistent with a role for PCs in
multiple events during epidermal differentiation.
Methods
Keratinocyte culture
Human foreskin keratinocytes were cultured using
the methods described by Fleckman et al. (18), a
modification of the Rheinwald–Green system.
Cells were harvested for RNA or protein at either
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∂60–70% of confluence, at 100% confluence or
several days post-confluence.
Detection of proprotein convertase expression in
skin using degenerate primers
The sequences of the known human PC members
(furin, PACE4, PC1, PC2, PC5/6, PC7/8) were ob-
tained from Genbank using the ENTREZ server.
The sequences were multiply aligned using Clus-
talW (19, 20) and a highly conserved region of the
catalytic domain was identified to which degener-
ate primers were designed. The sense primer (5ø-
CA(C/T) GG(C/G) AC(A/T/G/C) (A/C) G(A/T/G/
C) TGTGC (A/T/G) GG-3ø) was based on the se-
quence R194HGTRCAG201 in furin which contains
the active site arginine (R194). This sequence is
100% conserved across the known human mem-
bers of the PC family and highly conserved in
other species. The antisense primer (5ø-GG (T/G)
CCC CAG CT (T/G) (C/G) (A/C) (A/G) CTG TA-
3ø) was based on the sequence I249YSASWG255
which is also highly conserved across the family,
although in PC7/8 the alanine (A252) is replaced
by a cysteine. RT-PCR using these primers would
amplify a 187 bp segment from each PC that could
be distinguished on the basis of its nucleotide se-
quence.
Total RNA was isolated from 5-day post-con-
fluent cultured human keratinocytes using the Tri-
zol reagent (Life Technologies, Gaithersburg, MA,
USA) and the manufacturer’s protocol. After
DNase I treatment the total RNA was reverse
transcribed using the Superscript II RT system
(Life Technologies) and the resulting cDNA was
PCR amplified (40 cycles at 95 æC for 30 s; 60 æC
for 1 min; 72 æC for 1 min) using Taq plus Taq
extender (Promega, Madison, WI, USA). The re-
sulting 187 bp product was gel purified and TA
cloned into the pCR3.1 vector (Invitrogen,
Carlsbad, CA, USA).
Northern analysis
Total RNA was isolated from human foreskin
keratinocytes according to the method of Chom-
czynski & Sacchi (21), fractionated on glyoxal gels,
transferred to Genescreen Plus (Du Pont NEN,
Boston, MA, USA) by capillary blotting according
to manufacturer’s recommendation, and hybrid-
ized with radiolabeled cDNA probes specific for
the coding region of different members of the PC
family (22, 23). The blots were subsequently hy-
bridized with a GAPDH probe and the ratio be-
tween furin and GAPDH determined by Phos-
phorimager (Molecular Dynamics, Sunnydale,
CA, USA).
PC expression and localization in epidermis
RT-PCR analysis of PC5/6 and PC7/8
Oligoprimers specific for PC5/6 and PC7/8/LPC
were made according to published sequences (Gen-
bank acc. NM–004716). For PC5/6 the sense
primer used comprised nucleotides 962–982 (5ø-
TCA GCA GCA CTG CAG AAA GC-3ø) and the
antisense primer, nucleotides 1409–1429 (5ø-TGG
GGT CTT CAA CTC GGC TA-3ø), giving a 447
bp product. For PC7/8 the sense primer 163–183
(5ø-GCT GGT AGG CTG TTT CAC CG-3ø) and
667–647 (5ø-GGA TTG CTG CCA GAG AAG
TC-3ø) were used giving a 504 bp product. Reverse
transcription was performed on the total RNA
using the Superscript II kit (Life Technologies).
PCR analysis was performed using 32 cycles of 94
æC, 1 min; 50 æC, 45 s; 72 æC, 1 min using Taq poly-
merase (Promega). PCR products were analyzed
on a 1% agarose gel and their identity confirmed
by sequence analysis.
PC protein expression in epidermis and
keratinocytes
Protein from foreskin epidermis and cultured hu-
man keratinocytes was extracted using a modified
RIPA buffer (50mM HEPES, pH 7.5, 150 mM
NaCl, 50 mM NaF, 1% NP-40, 0.5% deoxycholate,
1 mM sodium vanadate, 1 mM nitrophenylphos-
phate, 5 mM benzamidine, 2 mM PMSF, 10 mg/ml
aprotonin, 1¿ complete protease inhibitor
(EDTA-free, Boehringer)) (24). The extracted pro-
teins were separated on 7.5–12% SDS–PAGE gels
and blotted onto nitrocellulose for western
immunoblot detection using specific antibodies
and ECL. Furin was detected using a polyclonal
antibody directed against the C-terminal tail (c-
fur) (a gift from Ruth Hogue Angeletti, New York
University, USA) and monoclonal antibodies
raised against catalytic domain (MON148) or cys-
teine-rich domain (MON152) epitopes (Alexis Bio-
chemicals, San Diego, CA, USA). PC7/8 was de-
tected using polyclonal antibodies directed against
the catalytic and C-terminal domains (gift from Dr
W. J. M. Van de Ven, Katholieke Universiteit Leuv-
en, Belgium). PACE4 was detected using an anti-
body directed to the pro and catalytic domains
(Alexis Biochemicals).
Localization of furin in epidermis
Immunofluorescence was performed on methanol
fixed frozen or paraffin embedded methyl-Carnoy’s
fixed human epidermis. Carnoy’s fixed tissues were
first rehydrated and from then on all sections were
treated the same. Antigen unmasking was per-
formed on selected sections by incubation with
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0.1% trypsin for a variable length of time (usually
3 min). After preblocking the sections with serum
specific for the secondary antibodies used, the sec-
tions were incubated with the primary antibodies
in TBS containing 1% BSA overnight at 4 æC. The
primary antibodies were detected with either
FITC-conjugated secondary antibodies (Vector,
Eugene, OR, USA) or biotin-conjugated second-
ary antibodies followed by streptavidin-conjugated
Texas Red (Vector). DNA was stained with 4ø,6-
diamidino-2-phenylindole dihydrochloride (DAPI,
0.001%). Sections were mounted in ProlongA
mounting medium (Molecular Probes, Eugene,
OR, USA). Images were obtained using a CCD
camera attached to an epifluorescence Nikon SA
microphot microscope.
Inhibition of proprotein convertases in cultured
keratinocytes
Mouse epidermal keratinocytes were cultured to
confluence as described previously (25). The PC in-
hibitor decanoyl-Arg-Val-Lys-Arg-chloromethyl-
ketone (Bachem, Torrence, CA, USA) (26) was
added to the medium at feeding. Cells shed into
the medium were collected by centrifugation and
extracted first in RIPA buffer (24) and the pellet
was subsequently re-extracted in 8.8 M urea-Tris
buffer (27). Equal amounts of protein were run on
SDS–PAGE gels, blotted, probed with specific
antibodies, including Notch-1 (a gift from L. Miln-
er, Fred Hutchinson Cancer Research Center, Se-
attle, WA, USA) and visualized by ECL.
In vitro cleavage of profilaggrin by furin and
PACE4
Preparation of furin and PACE4 enzymes. Transi-
ent transfectants of COS-1 or 293T cells with fur-
in, mutant furin, and PACE4 expression constructs
and with the control vector were performed as de-
scribed elsewhere (22). Conditioned media from
cells expressing soluble furin (furin), mutant sol-
uble furin with the active site altered from serine to
alanine (furin-SA), PACE4, and pMT3 (a control
vector) (22, 23, 28) were harvested and concen-
trated 10-fold using Centricon 10 (Amicon, Bever-
ly, MA, USA) in 0.2 M sodium acetate pH 5.5.
The concentrated media were stored in aliquots at
ª80 æC until use.
Construction and expression of the profilaggrin
substrate
The cDNA expression construct used for these
studies (referred to as pFLAG467proF) encodes
the amino-terminal 467 amino acids of human
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profilaggrin, including the entire amino-terminal
A π B domains, plus the truncated filaggrin se-
quence. Preparation of the construct is described
elsewhere (27). The construct encodes the 8 amino
acid FLAG epitope at its amino-terminus. The
profilaggrin cDNA construct was cloned into
pcDNA3 (Invitrogen) for in vitro expression
studies. COS-7 cells were transiently transfected
using LipofectAMINE (Life Technologies) with
5.5 mg of the profilaggrin cDNA constructs. Cells
were usually harvested 48 h after transfection and
lysates prepared in 0.25 M Tris/HCl, pH 7.8, using
three freeze/thaw cycles in dry ice-ethanol and 37
æC water baths. Solubilized cell extracts were clari-
fied by centrifugation at 12,000 r.p.m. for 10 min
and stored frozen in aliquots until use.
Site-directed in vitro mutagenesis
Site directed mutagenesis on double-stranded
pFLAG467proF DNA was performed using the
method based on the QuikChange mutagenesis kit
(Stratagene, LaJolla, CA, USA) to render a non-
conservative mutation, either at P1, P2, or P4 of
the cleavage site, from Arg/Lys to Ala. The three
mutagenic oligonucleotide primers (Life Technolo-
gies) were as follows (5ø to 3ø) (mutated bases are
underlined, and the amino acid changes produced










The altered PC cleavage sites were confirmed by
sequencing the mutated constructs.
Proprotein convertase cleavage assay and
immunoblotting procedure
COS-7 cell extracts containing the substrate were
incubated with conditioned or mock medium (en-
zyme or control prep) at 37 æC for 16 h in a final
volume of 50 ml of 0.1 M HEPES buffer (pH 7.0),
1 mM b-mercaptoethanol, and 5 mM CaCl2. The
reaction was terminated by the addition of SDS–
PAGE sample buffer and boiled before loading
onto a 12% or 12–15% gradient SDS-polyacryl-
amide gel. The gel was electroblotted to nitrocellu-
lose and the amino-terminal domain of profilag-
grin identified using the polyclonal anti-B1-peptide
antibody described previously (specific for the B
domain) (27).
196
Figure 1. Expression of PC family members in cultured human
keratinocytes and epidermis. (A) Northern analysis of total
RNA from subconfluent (S) and confluent (C) cultured human
keratinocytes. Medullo blastoma cell line (UW) was used as a
positive control for furin/PACE expression. RNA was fraction-
ated on a 1% glyoxal gel, blotted, and hybridized with DNA
probes specific for furin/PACE, PACE4, and profilaggrin. The
blots were subsequently hybridized with glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) to normalize the amount of
RNA. Molecular weight markers are designated on the left.
Both subconfluent and confluent (profilaggrin expressing) kera-
tinocytes expressed a 5 kb furin message and a similar sized
PACE4 transcript. The furin message was increased 3-fold in
confluent vs subconfluent cells. (B) RT-PCR analysis of total
RNA from foreskin epidermis (F) and from subconfluent (S),
confluent (C), and postconfluent (P) keratinocytes cultures.
Primers specific for PC5/6, PC8, and actin were used. Both cells
and tissue had detectable levels of PC5/6 and PC7/8.
Results
Members of the proprotein convertase family are
expressed in human keratinocytes
To determine if human epidermal keratinocytes ex-
press members of the PC family we analyzed
mRNA expression using degenerate primers di-
rected towards the active site of the PC family.
Cloning and sequencing of multiple products re-
sulted in identification of furin, PACE4, PC5/6 and
PC7/8. In order to confirm this expression pattern
we used Northern blot and RT-PCR analysis of
epidermal and cultured human keratinocyte RNA.
Northern analysis of total RNA from human kera-
tinocytes at subconfluence and confluence using
cDNA probes specific to human furin/PACE and
PACE4 shows hybridization signals with the mol-
ecular size of approximately 5 kb (Fig. 1A); similar
to the size of these mRNAs in other cells and
tissues (12). Quantitative Phosphorimager analysis
of the level of furin/PACE expression relative to
PC expression and localization in epidermis
GAPDH indicates that the level increased approxi-
mately 3-fold upon confluence. GAPDH express-
ion levels are unchanged in pre vs postconfluent
cells (29). Similar results were obtained with
PACE4 expression (Fig. 1A). As a control for
changes in keratinocyte gene expression with con-
fluence, the level of human profilaggrin mRNA
was evaluated. Profilaggrin expression increased
dramatically in the confluent cultures (Fig. 1A),
consistent with previous results (29). In addition,
mRNAs for PC5/6 and PC7/8/LPC were detected
by RT-PCR amplification using specific primers
(Fig. 1B) both in cultured keratinocytes and fore-
skin epidermis; the identity of these products was
confirmed by sequencing. Probes corresponding to
PC1/PC3, PC2, and PC4 were tested by Northern
blotting but did not hybridize to keratinocyte
RNA under the conditions used, nor were they de-
tected in RT-PCR experiments (data not shown), in
agreement with previous evidence suggesting that
these PC family members are specific to other cell
Figure 2. Western blots of PC expression in extracts of foreskin epidermis and cultured keratinocytes. Foreskin (F) and subconfluent
(S), confluent (C) and postconfluent (P) keratinocyte extracts were separated on 7.5–12% SDS–PAGE gels, transferred to nitrocellu-
lose and probed with specific antibodies using the ECL system. The positions of molecular weight standards are indicated on the
left. (A) Expression of furin. Antibody c-fur, specific for the C-terminal cytoplasmic domain, recognized a 97 kDa band in epidermal
and keratinocyte extracts. Antibodies directed against the active site (MON148) and cysteine-rich domain (MON152) recognized
97, 75, and 120 kDa bands (arrows), although the 120 kDa band was not detected in epidermal extracts. The 97 kDa band is
equivalent in size to the expressed furin cDNA construct from COS cells (lane fur in MON 148 and MON 152 blots), while the 75
kDa band is slightly smaller in size than the soluble furin construct lacking the transmembrane and C-terminal domain (lane sol in
MON 148 and MON 152 blots). The 120 kDa band detected in keratinocytes may correspond to the proenzyme. (B) Diagram of
furin indicating epitopes for the antibodies used in A. The transmembrane domain is shown in black and the position of the protein
truncation to produce the soluble form (sol) is shown by the waved line. (C) Expression of PACE4. Bands of 95 kDa, 75 kDa and
70 kDa (arrows) were recognized by the PACE4 polyclonal antibody in control PACE4 expressed in 293T cells (PACE4) and
subconfluent (S) and postconfluent (P) keratinocytes. (D) Expression of PC7/8. The active 75 kDa protein (arrow) is detected in
both subconfluent and postconfluent cells using antibodies to both the C-terminus (KP1) and the N-terminus (MP1).
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types or tissues (12). Thus, we have evidence for
expression of four members of the PC family in
epidermal keratinocytes.
Proprotein convertase protein expression in
epidermis and keratinocytes
Antibodies to the catalytic domain and cytoplasmic
domains of both furin and PC7/8 were used to
further examine expression and localization of these
proteins in epidermis (Figs 2, 3 & 4).
The 97 kDa mature furin was detected in fore-
skin epidermal extracts and in subconfluent and
postconfluent keratinocytes (Fig. 2A). The 97 kDa
protein was recognized by antibodies to the C-ter-
minal cytoplasmic domain (c-fur), catalytic do-
main (MON148) and the cys-rich domain
(MON152) indicating that it corresponds to the
mature enzyme after proteolytic removal of the
prepro domain. This band corresponds to the size
of a furin expressed in COS cells via a cDNA con-
Pearton et al.
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Figure 3. Double immunofluorescence of epidermis using the c-
fur and MON148 antibodies. (A) c-fur reaction. (B) MON148
reaction. (C) Merged c-fur and MON148 reactions; the yellow
color indicates where the green and red signals are superim-
posed to give yellow fluorescence. Tissue sections were trypsin
treated (0.01%, 1 min) and incubated overnight (4 æC) with the
rabbit polyclonal c-fur antibody and the mouse monoclonal
MON148 antibody. The c-fur antibody was detected with a
FITC-labeled anti-rabbit secondary antibody (green); the
MON148 was detected using a biotinylated anti-mouse second-
ary/Texas Red streptavidin ternary complex (red); DNA in nu-
clei was stained with DAPI (blue). The C-terminal antibody
(c-fur, A & C) stains both the basal and granular layer with
significantly reduced staining in the spinous layer. The catalytic
domain antibody (MON148, B & C) stains mainly the granular
layer with lighter spinous and very little basal staining. In the
granular layer the merged staining (C) shows both co-localiz-
ation (yellow) as well as patches of differential localization of
the C-terminus (green) and catalytic (red) domains.
struct. An additional 70–75 kDa band was ob-
served in epidermis and keratinocytes that reacted
with antibodies to the catalytic domain (MON148)
and cys-rich domain (MON152), but not the C-
terminal cytoplasmic domain (c-fur). This band is
slightly smaller than soluble furin produced from
a construct lacking the transmembrane and C-ter-
minal domains, indicating cleavage and removal of
the transmembrane domain in the tissue. A larger
band (∂120 kDa), possibly corresponding to the
proenzyme, was detected in keratinocytes but not
in foreskin epidermal extracts. The specificity and
identity of the bands recognized by the antibodies
was confirmed by stripping representative blots
and reprobing with an alternate antibody (data
not shown).
Three bands (96 kDa, 75 kDa and 70 kDa) posi-
tive for PACE4 were detected on western blots in
sub- and post-confluent keratinocyte extracts (Fig.
2C). PC7/8 protein was also detected in pre- and
post-confluent keratinocytes (Fig. 2D). The active
form at ∂75 kDa was seen in both pre- and post-
confluent cell extracts with both antibodies.
Localization of proprotein convertases in epidermis
Furin staining was detected by immunofluorescent
localization within the epidermis. The antibody to
the cytoplasmic domain (c-fur) showed strong
staining in the basal and granular layers with less
staining in the spinous layers (Fig. 3A). In contrast
the antibody against the active site (MON148)
showed the greatest concentration of staining in
the granular layer (MON148; Fig. 3B), with less
staining in the lower layers of the epidermis. The
staining was strongly cytoplasmic. In the granular
layer the staining pattern for the cytoplasmic do-
main (c-fur) and catalytic domain (MON148) were
not completely correlated (Fig. 3C). Areas of yel-
PC expression and localization in epidermis
Figure 4. Immunofluorescence of epidermis using antibodies
specific for PC7/8. (A) Staining with the antibody KP1 which
is directed at an epitope in the C-terminal cytoplasmic domain.
(B) Staining with antibody MP1 which recognizes the N-ter-
minus of the catalytic domain. Tissue sections were incubated
with the polyclonal KP1 or MP1 (1 h, RT) and detected using
a FITC-labeled anti-rabbit secondary (green). Nuclei were
stained with DAPI (blue). Both antibodies stained all layers of
the epidermis and were confined to the cytoplasm of the cells.
Note the slight increase of staining in the granular layer.
low in the granular layer indicate where the red
MON148 staining and green c-fur staining are col-
ocalized (merged). There are, however, significant
areas where the two antibodies are not superim-
posed (red and green staining in the granular
layer). Strong furin staining was also seen in the
glandular structures of the dermis (not shown).
Antibodies specific for PC7/8 showed patchy
staining throughout the epidermis (Fig. 4). This
distribution was similar with both the antibody di-
rected against the C-terminal cytoplasmic domain
(KP1) (Fig. 4A) and that directed against the cata-
lytic domain (MP1) (Fig. 4B).
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Figure 5. Inhibition of Notch-1 processing in mouse keratino-
cytes by decanocyl-RVKR-CMK. Mouse keratinocytes were
treated with the inhibitor or vehicle for 4 days. Cell extracts
were separated on a 7.5–15% SDS–PAGE gel, blotted onto
nitrocellulose and probed with a monoclonal anti-Notch-1 anti-
body directed to an epitope in the intracellular C-terminal do-
main using the ECL system. The 120 kDa active Notch-1
amino-terminal domain (*) is detected in the pretreated cultures
(day 2) as well as in the day 4 cultures without the PC inhibitor
but is significantly reduced in cultures treated with 100 mM and
250 mM of the inhibitor. The position of molecular weight stan-
dards is shown on the left. The Notch-1 pro-form is not de-
tected due to its poor reactivity with the antibody (Milner, per-
sonal communication).
Identification of potential PC substrates in
epidermis
Two potential substrates, Notch-1 and profilag-
grin, relevant in epidermal differentiation, were in-
vestigated using either in vivo or in vitro ap-
proaches.
Inhibition of Notch-1 processing by inhibition of
proprotein convertase processing in culture
Notch-1 is a cell-surface receptor involved in cell
fate determination and patterning. Processing of
Notch-1 by furin at an RXRR site in the carboxy
terminus during transport to the plasma mem-
brane is required to produce the functional recep-
tor (14, 30). A cell permeable PC inhibitor (de-
canoyl-RVKR-CMK) (26) was added to mouse
keratinocyte cultures to test the role of furin on
Notch-1 processing in these cells. Inhibition of the
processing of Notch-1 from the precursor form
(220 kDa) to the functional 120 kDa form (Fig. 5)
was seen with dramatic reduction of the 120 kDa
form using both 100 and 250 mM of the inhibitor.
The inhibitor did not exhibit toxic effects on the
cells at these concentrations.
Furin and PACE4 specifically cleave the amino
terminus of profilaggrin
Profilaggrin is a large (.400 kDa) protein, com-
prised of multiple filaggrin domains flanked by
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unique N and C-termini, that is expressed in the
granular layer of the epidermis (reviewed in 31).
Normal keratinocyte culture systems can be in-
duced to produce profilaggrin (18, 29, 32) but do
not fully process it into filaggrin and the amino-
terminal fragment. Therefore, to study potential
PC processing of profilaggrin at the predicted se-
quence (R288TRKRR293) at the junction of the
amino terminus and the filaggrin domains, an in
vitro system was used. Extracts obtained from
COS-7 cells transfected with the N-terminal profi-
laggrin expression construct, pFLAG467proF,
were used to mimic profilaggrin; profilaggrin itself
is insoluble in aqueous buffers suitable for enzyme
assays and therefore could not be used in these as-
says. Media conditioned by COS-1 or 293T cells
transfected with expression constructs encoding
either a soluble form of furin, its inactive mutant
derivative (furin-SA), or PACE4 were sources of
the enzymes. Cleavage of the substrate was de-
Figure 6. Cleavage of profilaggrin (pFLAG467proF) by furin
and PACE4. Extracts of COS-7 cells transfected with the
pFLAG467proF were incubated with conditioned media con-
taining expressed enzyme. The products were analyzed using
antibody specific for the B domain of the profilaggrin amino-
terminus. The position of uncleaved product is shown by the
arrow. Note that a cleaved product (approx. 37 kDa*) is de-
tected in the samples containing furin (strong) and PACE4
(weak), but not those containing an inactive mutant (furin-SA)
or mock transfected media or the unreacted substrate (hABfg).
The endogenous profilaggrin N-terminus (32 kDa) is visible in
the foreskin extract (arrowhead). Molecular weight markers are
indicated on the left. A diagram of the FLAG467proF con-
struct is shown to illustrate the A and B domains and the posi-
tion of the predicted cleavage site.
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tected by the appearance of the processed fragment
on western blots using antibodies specific for the
B domain of the profilaggrin N-terminus. The
antibody specific for the amino-terminus reacts
with both the amino-terminal-profilaggrin sub-
strate and the expected cleavage product (Fig. 6),
whereas the antibody specific for filaggrin reacts
only with the amino-terminal-profilaggrin sub-
strate and not with the cleaved product (data not
shown). As shown in Fig. 6, only treatment of the
profilaggrin substrate with the soluble form of fur-
in or with PACE4 but not with the mutant furin
(furin-SA) resulted in the appearance of a new
band representing the proteolytic cleavage product
with a size of approximately 37 kDa. This cleavage
is Ca2π-dependent and can be inhibited with
EDTA (data not shown). Control substrate (von
Willebrand factor or CPA-PACE) was used to ver-
ify that the enzyme preparations functioned as ex-
pected (data not shown).
In order to confirm the specific site of PC cleav-
age, the proposed cleavage site (R288TRKRR293)
was mutated to see if specific processing could be
affected. Fig. 7 shows that substitution at either
the P1 position (to RKRA) or the P4 position (to
AKRR) virtually abolished the cleavage which
produces the 37 kDa product in the normal con-
struct, whereas the alteration of the P2 position (to
RKAR) had little effect on the cleavage. The re-
sults demonstrated that the predicted paired amino
acid sequence is required as the primary target site
Figure 7. Effect of mutation at residues P1, P2, and P4 of the
putative profilaggrin cleavage site. COS-7 cells were transfected
with the profilaggrin expression construct carrying either the
parental (RKRR) or one of the mutant cleavage sites (RKRA,
RKAR, AKRR) and the extracts were treated with conditioned
media containing mock media (lane 1) or soluble furin (lane 2).
The 37 kDa cleaved product is visible in the furin cleaved-par-
ental construct and the RKAR mutant and was identified using
the antibody specific for the profilaggrin B-domain (*). The
normal 37 kDa cleavage product is absent from the RKRA and
AKRR mutants although a secondary cleavage product at 40
kDa is seen (arrowhead). Molecular weights are indicated on
the left. Lane F is human foreskin extract run as a control on
the same gel showing the 32 kDa endogenous cleavage product.
PC expression and localization in epidermis
for furin/PACE cleavage in vitro. Interestingly, mu-
tagenesis of each of the critical residues (P1, P4)
yielded another cleaved product migrating at
about 40 kDa. This product could be either an in-
termediate of a sequential cleavage or a product
resulting from an alternative secondary site, poss-
ibly the sequence GSRHPR present at residues
331–336.
Discussion
The dramatic remodeling of cytoplasm and cell
membrane that occurs at the transition of the
granular and cornified layers to form the protec-
tive skin surface requires multiple proteolytic
events, breakdown of nucleic acids and membrane-
bounded cellular organelles, and restructuring of
the keratin cytoskeleton and plasma membrane.
The changes in keratinocytes during the basal to
spinous layer transition are not as dramatic
morphologically yet regulate the balance between
proliferation and withdrawal from the cell cycle
and differentiation. The results presented here
show that members of the PC family are likely to
play a role in these events, consistent with their
involvement in differentiation of gut epithelia and
other tissues (33).
We have shown the expression in epidermis of
four PC family members; furin, PACE4, PC5/6
and PC7/8 at the mRNA level and detected protein
for three of these proteases. Furin, in particular, is
detected in two forms – the mature 97 kDa form
and a smaller 75 kDa form that lacks reactivity
with the c-fur antibody specific for the C-terminus.
Based on size and antibody reactivity, the 75 kDa
form is expected to lack the transmembrane do-
main. This size difference may be associated with
the change in the accessibility of furin in the differ-
ent layers of the skin shown by immunocytochemi-
stry using antibodies directed to specific epitopes.
The cytoplasmic C-terminal domain is detected in
both the basal (less differentiated) layer and the
granular layer whereas the catalytic domain is
most readily detected in the granular layer where
cells are preparing to undergo terminal differen-
tiation. This implies that the catalytic domain is
more accessible to the antibody in the granular
cells. As the cells of the granular layer are under-
going significant remodeling, including the dissol-
ution of membranous organelles and the remodel-
ing of the golgi/transgolgi apparatus into lamellar
granules (34–36), it is likely that there is some re-
arrangement of the normal contents of these or-
ganelles, including the normally trans-golgi resi-
dent furin, which would allow it access to a wider
range of substrates in these cells.
These results suggest that furin might play
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multiple roles in epidermal differentiation depend-
ing on the cell layer. Thus in the basal layer it
would be expected to be involved in processing of
secreted substrates including collagen XVII, inte-
grins a3 and a6, and Notch, which mature via the
golgi–transgolgi route. Our studies clearly show
that inhibition of furin (and other PCs) in kera-
tinocytes blocked the processing of Notch-1, a cell
surface receptor that has been shown to be in-
volved in cell fate determination and patterning
(37–41) and integrin signaling (17). Notch is ex-
pressed in all layers of the epidermis and has been
suggested to have a role in stem cell fate and main-
tenance in epidermis (15) and hair follicles (42, 43).
The potential importance of the Notch pathway is
emphasized by the expression of the fringe genes,
modulators of Notch signaling, in specific patterns
in epidermis (44). Furin over-expression has been
shown to inhibit differentiation in a-cells of pan-
creatic islets (45) and gastric mucosal cells (33). In
contrast inhibition of furin in epidermal or-
ganotypic cultures leads to premature differen-
tiation of keratinocytes, possibly via its effects on
the Notch pathway (Pearton et al., in preparation).
Furin is not strongly expressed in the spinous
layers, but is detectable in the granular layer with
altered epitope accessibility correlated with detec-
tion of the 75 kDa form of the enzyme. In this
layer furin, and other PCs, would have access to a
different range of substrates including cytoplasmic
proteins such as profilaggrin. Both furin and
PACE4 are able to cleave profilaggrin in vitro to
release a fragment of the size predicted by cleavage
at the junction with the filaggrin domains (27).
PC5/6 and PC7/8 are also expressed in the epider-
mis but it is not known whether they have similar
cleavage specificity towards the profilaggrin sub-
strate.
Profilaggrin is a highly phosphorylated insol-
uble protein of keratohyalin. During terminal dif-
ferentiation it is processed by phosphatases and
proteases to release the amino-terminus and indi-
vidual filaggrin domains which bind to and aggre-
gate keratin filaments (46). Although several en-
zymes involved in profilaggrin processing are
known, the early events are not understood (re-
viewed in 31). The amino-terminus containing the
S-100 Ca2π-binding domain (A domain) and a cat-
ionic B domain moves to the nucleus in transition
cells while the filaggrin domains remain in the
cytoplasm (47) (27, 48). A canonical PC cleavage
motif (R288TRKRR293) lies at the junction be-
tween the B domain and the first filaggrin repeat.
This site is very different from the hydrophobic
cleavage motif (FLY in human) located between
the filaggrin repeats (5, 49) which is the target of
specific proteases such as PEP1 (5). The domain-
Pearton et al.
specific cleavage of profilaggrin in vitro (37 kDa
product) is similar but not identical to that de-
tected in vivo (approx. 32 kDa) (Figs 6, 7). This
difference could be due in part to the presence of
the FLAG epitope which was required to enhance
solubility of this test substrate. However, ad-
ditional cleavages may also occur in vivo, and
further study will be required to determine the in-
volvement of PC in this processing pathway in vivo.
Nevertheless, cleavage of the profilaggrin
amino-terminus is a critical event for altering the
solubility of the protein for subsequent PEP1
cleavage of the filaggrin units (Resing et al., sub-
mitted), as well as for generating the S-100-like do-
main for nuclear translocation where it may have
distinct functions in calcium-regulated events dur-
ing terminal differentiation (47, 48, 50, 51). The
profilaggrin domain-specific processing, the furin
localization and its change in accessibility during
differentiation, and the calcium-dependent pro-
cessing, all suggest a functional role for PCs in ter-
minal differentiation in vivo. Our findings empha-
size the pivotal role of proteases in processing pro-
filaggrin and adds furin/PACE to the list of
proteases (i.e. profilaggrin endoproteinase 1 (5),
calpain (52), plasmin and chymotrypsin-like pro-
teases (53)) that are likely to have significant roles
in terminal differentiation of epidermal cells.
In summary we present the first systematic
analysis into the expression and localization of the
PCs in epidermis. We have shown the localization
of furin and PC7/8 using immunofluorescence and
present evidence that furin undergoes a change of
accessibility between the basal and granular layers
that is related to cleavage to a soluble form that
would have access to different types of substrates
in these two distinct sites. We show that inhibition
of PCs in keratinocytes inhibits processing of
Notch-1, a known substrate with implications for
cell fate determination and patterning. We also
demonstrate that PCs are able to specifically cleave
the amino-terminus of profilaggrin, a novel sub-
strate found in the granular layer of the epidermis.
This work indicates that the PCs may play multiple
roles during the differentiation of cells within the
epidermis.
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